339 related articles for article (PubMed ID: 18595765)
21. Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.
Hanna-Pladdy B; Enslein A; Fray M; Gajewski BJ; Pahwa R; Lyons KE
Int J Neurosci; 2010 Aug; 120(8):538-43. PubMed ID: 20615057
[TBL] [Abstract][Full Text] [Related]
22. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
Cammisuli DM; Sportiello MT
Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
[TBL] [Abstract][Full Text] [Related]
23. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.
Chahine LM; Weintraub D; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D;
Mov Disord; 2016 Jan; 31(1):86-94. PubMed ID: 26293177
[TBL] [Abstract][Full Text] [Related]
24. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.
Lawson RA; Yarnall AJ; Duncan GW; Khoo TK; Breen DP; Barker RA; Collerton D; Taylor JP; Burn DJ
Parkinsonism Relat Disord; 2014 Oct; 20(10):1071-5. PubMed ID: 25074728
[TBL] [Abstract][Full Text] [Related]
25. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
van Steenoven I; Aarsland D; Hurtig H; Chen-Plotkin A; Duda JE; Rick J; Chahine LM; Dahodwala N; Trojanowski JQ; Roalf DR; Moberg PJ; Weintraub D
Mov Disord; 2014 Dec; 29(14):1809-15. PubMed ID: 25381961
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
27. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
28. Defining mild cognitive impairment in Parkinson's disease.
Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
[TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
[TBL] [Abstract][Full Text] [Related]
30. Mini mental Parkinson test: standardization and normative data on an Italian sample.
Costa A; Bagoj E; Monaco M; Zabberoni S; De Rosa S; Mundi C; Caltagirone C; Carlesimo GA
Neurol Sci; 2013 Oct; 34(10):1797-803. PubMed ID: 23479031
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
32. The pill questionnaire in a nondemented Parkinson's disease population.
Reginold W; Armstrong MJ; Duff-Canning S; Lang A; Tang-Wai D; Fox S; Rothberg B; Zadikoff C; Kennedy N; Gill D; Eslinger P; Mapstone M; Chou K; Persad C; Litvan I; Mast B; Marras C
Mov Disord; 2012 Sep; 27(10):1308-11. PubMed ID: 22865587
[TBL] [Abstract][Full Text] [Related]
33. Measuring mild cognitive impairment in patients with Parkinson's disease.
Marras C; Armstrong MJ; Meaney CA; Fox S; Rothberg B; Reginold W; Tang-Wai DF; Gill D; Eslinger PJ; Zadikoff C; Kennedy N; Marshall FJ; Mapstone M; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Duff-Canning S
Mov Disord; 2013 May; 28(5):626-33. PubMed ID: 23520128
[TBL] [Abstract][Full Text] [Related]
34. Evaluating cognitive impairment in the early stages of Parkinson's disease using the Cambridge brain sciences-cognitive platform.
Hosseini M; Borhani-Haghighi A; Petramfar P; Foroughi AA; Ostovan VR; Nami M
Clin Neurol Neurosurg; 2023 Sep; 232():107866. PubMed ID: 37413872
[TBL] [Abstract][Full Text] [Related]
35. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
36. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
[TBL] [Abstract][Full Text] [Related]
37. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
Aarsland D; Bronnick K; Williams-Gray C; Weintraub D; Marder K; Kulisevsky J; Burn D; Barone P; Pagonabarraga J; Allcock L; Santangelo G; Foltynie T; Janvin C; Larsen JP; Barker RA; Emre M
Neurology; 2010 Sep; 75(12):1062-9. PubMed ID: 20855849
[TBL] [Abstract][Full Text] [Related]
38. Cognitive Deficits in Healthy Elderly Population With "Normal" Scores on the Mini-Mental State Examination.
Votruba KL; Persad C; Giordani B
J Geriatr Psychiatry Neurol; 2016 May; 29(3):126-32. PubMed ID: 26850856
[TBL] [Abstract][Full Text] [Related]
39. Deficit in specific cognitive domains associated with dementia in Parkinson's disease.
Pal A; Pegwal N; Kaur S; Mehta N; Behari M; Sharma R
J Clin Neurosci; 2018 Nov; 57():116-120. PubMed ID: 30150061
[TBL] [Abstract][Full Text] [Related]
40. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
